Login / Signup

Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.

Julie C RefardtCornelia ImberRianne NobbenhuisClara Odilia SailerAaron HaslbauerSophie MonneratCemile BatheltDeborah R VogtManfred BerresBettina WinzelerStephanie A BridenbaughMirjam Christ-Crain
Published in: Journal of the American Society of Nephrology : JASN (2022)
ClinicalTrials.gov NCT03202667.
Keyphrases
  • placebo controlled
  • double blind
  • phase iii
  • phase ii
  • study protocol
  • clinical trial
  • open label
  • phase ii study
  • radiation therapy
  • drug induced